Price at previous close
$0.03
Market cap 13.07K
InvestorsCraft valuation
Fair value (AI, DCF / IC, Graham) for Aclarion, Inc. (ACONW) is available to Pro members and via the machine API.
- AI valuation — available
- Intrinsic / IC value — available
- Upside vs price — available
Line items
Line items
Line items
About Aclarion, Inc.
Aclarion, Inc. is a healthcare technology firm specializing in software development for magnetic resonance spectroscopy (MRS) within the U.S. market. Its flagship product is the NOCISCAN-LS Post-Processor suite. This comprehensive suite includes NOCICALC-LS, which processes magnetic resonance spectroscopy (MRS) data from spinal discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a vital clinical decision support tool. Initially named Nocimed, Inc., the company adopted the Aclarion, Inc. moniker in December 2021. Established in 2008, Aclarion, Inc. maintains its headquarters in San Mateo, California.
- CEO
- Brent Ness
- Employees
- 11
- Beta
- 1.21
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice.